BXRX

Baudax Bio, Inc. Common Stock

Delisted

BXRX was delisted on the 15th of November, 2023.

 

About: Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs.

Employees: 9

Charts implemented using Lightweight Charts™